Original Research
Published on 15 Nov 2021
OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.650678
- 3,870 views
- 7 citations
